Peptide antiangiogenic drugs

   
   

Peptides having the formula: A.sub.0 -A.sub.1 -A.sub.2 -A.sub.3 -A.sub.4 -A.sub.5 -A.sub.6 -A.sub.7 -A.sub.8 -A.sub.9 -A.sub.10 wherein A.sub.0 is selected from hydrogen or an acyl group; A.sub.10 is a hydroxyl group or an amino acid amide; and A.sub.1, A.sub.2, A.sub.3, A.sub.4, A.sub.5, A.sub.6, A.sub.7, A.sub.8, and A.sub.9 are amino acyl residues as defined herein.

Peptides que tienen el fórmula: A.sub.0 - A.sub.1 - A.sub.2 - A.sub.3 - A.sub.4 - A.sub.5 - A.sub.6 - A.sub.7 - A.sub.8 - A.sub.9 - A.sub.10 en donde A.sub.0 se selecciona del hidrógeno o de un grupo del acyl; A.sub.10 es un grupo del oxhidrilo o una amida del aminoácido; y A.sub.1, A.sub.2, A.sub.3, A.sub.4, A.sub.5, A.sub.6, A.sub.7, A.sub.8, y A.sub.9 son residuos amino del acyl según lo definido adjunto.

 
Web www.patentalert.com

< Drug-carrier complexes and methods of use thereof

< Methods of ultrasound treatment using gas or gaseous precursor-filled compositions

> Modified vitamin K-dependent polypeptides

> Device and methods for subdividing and filtering gel material and extracting molecules therefrom

~ 00107